Galderma Laboratories, makers of Cetaphil, is celebrating the fifth consecutive year of its “Meaningphil” partnership with the Children’s Skin Disease Foundation (CSDF) and Camp Wonder, an initiative of the CSDF. What began as a product sponsorship has evolved into a long-term commitment to raising awareness of skin diseases, with Galderma and Cetaphil providing not only product, but grants, volunteers and sponsored activities as a part of their partnership with the CSDF.
Camp Wonder is a medically staffed summer program that invites children ages 7 to 16 who suffer from severe and life-threatening skin diseases to experience the joys of being a kid at summer camp. The weeklong camp is funded by the CSDF, founded in May 2000 by Francesca Tenconi.
This past June, the CSDF hosted 100 children in Livermore, California, for a week of various summer camp activities. This year's theme was “CSDF Olympics,” and Cetaphil invited U.S. paralympic athlete, Megan Absten, for a surprise visit to the camp, where she kicked off the games and spoke to the children about her journey of achievement in the face of adversity, empowering them to do the same. Campers also enjoyed various events throughout the week, including the annual prom night, talent show and movie night, plus Cetaphil-sponsored activities such as a bean bag toss, and a prize wheel where campers spun to win assorted Cetaphil merchandise, products and candy. Galderma sent the highest number of volunteers to date, including Cetaphil representatives who were all on-site to help staff where needed.
“I am beyond grateful for the support that the CSDF has received from Galderma and Cetaphil over the last five years. Our partnership is a special one, where together we are able to touch the lives of so many children affected by chronic skin diseases,” said Tenconi. “We’re so fortunate to have sponsors like Galderma and Cetaphil to help us create a place where these children can feel comfortable in their own skin and experience the joys of summer camp like other kids their age.”
